A recent drug trial yields encouraging results.
David Margolin, MD, PhD
Advertisement
Dr Margolin is senior vice-president, clinical and translational medicine at Cerevance, Inc.
Articles by David Margolin, MD, PhD
Advertisement
Latest Updated Articles
Treating Cognitive Impairment in Patients with SchizophreniaPublished: November 20th 2020 | Updated:
Advertisement
Advertisement
Trending on Psychiatric Times
1
Loneliness, Meet Solitude
2
FDA Approves Uzedy Once-Monthly Extended Release Injectable Suspension for Bipolar I Disorder
3
How to Approach Conversations With Adult Patients Who Might Have ADHD: New Tools and Insights
4
Accessory to War
5
